rs61757111
Positions:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2
The NM_001378452.1(ITPR1):c.5265C>T(p.Asn1755Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00292 in 1,613,816 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0021 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 5 hom. )
Consequence
ITPR1
NM_001378452.1 synonymous
NM_001378452.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.344
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 3-4733132-C-T is Benign according to our data. Variant chr3-4733132-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 197067.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=2, Benign=3}. Variant chr3-4733132-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.344 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00209 (319/152336) while in subpopulation NFE AF= 0.00357 (243/68034). AF 95% confidence interval is 0.0032. There are 2 homozygotes in gnomad4. There are 140 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITPR1 | NM_001378452.1 | c.5265C>T | p.Asn1755Asn | synonymous_variant | 43/62 | ENST00000649015.2 | NP_001365381.1 | |
ITPR1 | NM_001168272.2 | c.5220C>T | p.Asn1740Asn | synonymous_variant | 42/61 | NP_001161744.1 | ||
ITPR1 | NM_001099952.4 | c.5121C>T | p.Asn1707Asn | synonymous_variant | 40/59 | NP_001093422.2 | ||
ITPR1 | NM_002222.7 | c.5076C>T | p.Asn1692Asn | synonymous_variant | 39/58 | NP_002213.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITPR1 | ENST00000649015.2 | c.5265C>T | p.Asn1755Asn | synonymous_variant | 43/62 | NM_001378452.1 | ENSP00000497605.1 | |||
ITPR1 | ENST00000354582.12 | c.5241C>T | p.Asn1747Asn | synonymous_variant | 43/62 | 5 | ENSP00000346595.8 | |||
ITPR1 | ENST00000648266.1 | c.5238C>T | p.Asn1746Asn | synonymous_variant | 43/62 | ENSP00000498014.1 | ||||
ITPR1 | ENST00000650294.1 | c.5223C>T | p.Asn1741Asn | synonymous_variant | 42/61 | ENSP00000498056.1 | ||||
ITPR1 | ENST00000443694.5 | c.5220C>T | p.Asn1740Asn | synonymous_variant | 42/61 | 1 | ENSP00000401671.2 | |||
ITPR1 | ENST00000648309.1 | c.5193C>T | p.Asn1731Asn | synonymous_variant | 40/59 | ENSP00000497026.1 | ||||
ITPR1 | ENST00000357086.10 | c.5121C>T | p.Asn1707Asn | synonymous_variant | 40/59 | 1 | ENSP00000349597.4 | |||
ITPR1 | ENST00000456211.8 | c.5076C>T | p.Asn1692Asn | synonymous_variant | 39/58 | 1 | ENSP00000397885.2 | |||
ITPR1 | ENST00000648038.1 | c.3027C>T | p.Asn1009Asn | synonymous_variant | 23/42 | ENSP00000497872.1 | ||||
ITPR1 | ENST00000648431.1 | c.2565C>T | p.Asn855Asn | synonymous_variant | 21/39 | ENSP00000498149.1 | ||||
ITPR1 | ENST00000648212.1 | c.2172C>T | p.Asn724Asn | synonymous_variant | 19/39 | ENSP00000498022.1 |
Frequencies
GnomAD3 genomes AF: 0.00209 AC: 318AN: 152218Hom.: 2 Cov.: 33
GnomAD3 genomes
AF:
AC:
318
AN:
152218
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00192 AC: 478AN: 248698Hom.: 0 AF XY: 0.00189 AC XY: 255AN XY: 134938
GnomAD3 exomes
AF:
AC:
478
AN:
248698
Hom.:
AF XY:
AC XY:
255
AN XY:
134938
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00301 AC: 4400AN: 1461480Hom.: 5 Cov.: 31 AF XY: 0.00288 AC XY: 2094AN XY: 727008
GnomAD4 exome
AF:
AC:
4400
AN:
1461480
Hom.:
Cov.:
31
AF XY:
AC XY:
2094
AN XY:
727008
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00209 AC: 319AN: 152336Hom.: 2 Cov.: 33 AF XY: 0.00188 AC XY: 140AN XY: 74478
GnomAD4 genome
AF:
AC:
319
AN:
152336
Hom.:
Cov.:
33
AF XY:
AC XY:
140
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:5
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 11, 2014 | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2023 | ITPR1: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 18, 2020 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 31, 2020 | - - |
Autosomal dominant cerebellar ataxia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at